In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil

Detalhes bibliográficos
Autor(a) principal: Nogueira Brilhante, Raimunda Samia [UNIFESP]
Data de Publicação: 2016
Outros Autores: Rodrigues, Anderson Messias [UNIFESP], Costa Sidrim, Jose Julio [UNIFESP], Gadelha Rocha, Marcos Fabio [UNIFESP], Pereira, Sandro Antonio, Ferreira Gremiao, Isabella Dib, Pacheco Schubach, Tania Maria, de Camargo, Zoilo Pires [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: https://repositorio.unifesp.br/handle/11600/57889
http://dx.doi.org/10.1093/mmy/myv039
Resumo: Sporotrichosis is an important subcutaneous mycosis of humans and animals. Classically, the disease is acquired upon traumatic inoculation of Sporothrix propagules from contaminated soil and plant debris. In addition, the direct horizontal transmission of Sporothrix among animals and the resulting zoonotic infection in humans highlight an alternative and efficient rout of transmission through biting and scratching. Sporothrix brasiliensis is themost virulent species of the Sporothrix schenckii complex and is responsible for the long-lasting outbreak of feline sporotrichosis in Brazil. However, antifungal susceptibility data of animal-borne isolates is scarce. Therefore, this study evaluated the in vitro activity of amphotericin B, caspofungin, itraconazole, voriconazole, fluconazole, and ketoconazole against animal-borne isolates of S. brasiliensis. The susceptibility tests were performed through broth microdilution (M38-A2). The results show the relevant activity of itraconazole, amphotericin B, and ketoconazole against S. brasiliensis, with the following MIC ranges: 0.125-2, 0.125-4 and 0.0312-2 mu g/ml, respectively. Caspofungin was moderately effective, displaying higher variation in MIC values (0.25-64 mu g/ml). Voriconazole (2-64 mu g/ml) and fluconazole (62.5-500 mu g/ml) showed low activity against S. brasiliensis strains. This study contributed to the characterization of the in vitro antifungal susceptibility of strains of S. brasiliensis recovered from cats with sporotrichosis, which have recently been considered the main source of human infections.
id UFSP_e393aba7bc0b2f5fee46fd87db41121b
oai_identifier_str oai:repositorio.unifesp.br:11600/57889
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Nogueira Brilhante, Raimunda Samia [UNIFESP]Rodrigues, Anderson Messias [UNIFESP]Costa Sidrim, Jose Julio [UNIFESP]Gadelha Rocha, Marcos Fabio [UNIFESP]Pereira, Sandro AntonioFerreira Gremiao, Isabella DibPacheco Schubach, Tania Mariade Camargo, Zoilo Pires [UNIFESP]2020-08-21T17:00:09Z2020-08-21T17:00:09Z2016Medical Mycology. Oxford, v. 54, n. 3, p. 275-279, 2016.1369-3786https://repositorio.unifesp.br/handle/11600/57889http://dx.doi.org/10.1093/mmy/myv03910.1093/mmy/myv039WOS:000372105200007Sporotrichosis is an important subcutaneous mycosis of humans and animals. Classically, the disease is acquired upon traumatic inoculation of Sporothrix propagules from contaminated soil and plant debris. In addition, the direct horizontal transmission of Sporothrix among animals and the resulting zoonotic infection in humans highlight an alternative and efficient rout of transmission through biting and scratching. Sporothrix brasiliensis is themost virulent species of the Sporothrix schenckii complex and is responsible for the long-lasting outbreak of feline sporotrichosis in Brazil. However, antifungal susceptibility data of animal-borne isolates is scarce. Therefore, this study evaluated the in vitro activity of amphotericin B, caspofungin, itraconazole, voriconazole, fluconazole, and ketoconazole against animal-borne isolates of S. brasiliensis. The susceptibility tests were performed through broth microdilution (M38-A2). The results show the relevant activity of itraconazole, amphotericin B, and ketoconazole against S. brasiliensis, with the following MIC ranges: 0.125-2, 0.125-4 and 0.0312-2 mu g/ml, respectively. Caspofungin was moderately effective, displaying higher variation in MIC values (0.25-64 mu g/ml). Voriconazole (2-64 mu g/ml) and fluconazole (62.5-500 mu g/ml) showed low activity against S. brasiliensis strains. This study contributed to the characterization of the in vitro antifungal susceptibility of strains of S. brasiliensis recovered from cats with sporotrichosis, which have recently been considered the main source of human infections.Sao Paulo Research Foundation (FAPESP)National Council for Scientific and Technological Development (CNPq 304779/20113)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Programa Estrategico de Apoio a Pesquisa em Saude VI - Fiocruz/CNPqFundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Univ Fed Ceara, Specialized Med Mycol Ctr, Postgrad Program Med Microbiol, Fortaleza, Ceara, BrazilUniv Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Cellular Biol Div, Sao Paulo, BrazilFundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, BrazilUniv Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Cellular Biol Div, Sao Paulo, BrazilFAPESP: 2011/07350-1FAPESP: 2009/54024-2CNPq: 304779/20113CAPES: AE1-0052-000650100/11Fiocruz/CNPq: 407771/2013-3FAPERJ: E-26/102.255/2013Web of Science275-279engOxford Univ PressMedical MycologySporothrix brasiliensiscatsantifungal susceptibilitysporotrichosisSporothrix schenckii complexIn vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazilinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleOxford543info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/578892022-02-08 11:52:11.563metadata only accessoai:repositorio.unifesp.br:11600/57889Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-05-25T12:18:07.361143Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil
title In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil
spellingShingle In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil
Nogueira Brilhante, Raimunda Samia [UNIFESP]
Sporothrix brasiliensis
cats
antifungal susceptibility
sporotrichosis
Sporothrix schenckii complex
title_short In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil
title_full In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil
title_fullStr In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil
title_full_unstemmed In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil
title_sort In vitro susceptibility of antifungal drugs against Sporothrix brasiliensis recovered from cats with sporotrichosis in Brazil
author Nogueira Brilhante, Raimunda Samia [UNIFESP]
author_facet Nogueira Brilhante, Raimunda Samia [UNIFESP]
Rodrigues, Anderson Messias [UNIFESP]
Costa Sidrim, Jose Julio [UNIFESP]
Gadelha Rocha, Marcos Fabio [UNIFESP]
Pereira, Sandro Antonio
Ferreira Gremiao, Isabella Dib
Pacheco Schubach, Tania Maria
de Camargo, Zoilo Pires [UNIFESP]
author_role author
author2 Rodrigues, Anderson Messias [UNIFESP]
Costa Sidrim, Jose Julio [UNIFESP]
Gadelha Rocha, Marcos Fabio [UNIFESP]
Pereira, Sandro Antonio
Ferreira Gremiao, Isabella Dib
Pacheco Schubach, Tania Maria
de Camargo, Zoilo Pires [UNIFESP]
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Nogueira Brilhante, Raimunda Samia [UNIFESP]
Rodrigues, Anderson Messias [UNIFESP]
Costa Sidrim, Jose Julio [UNIFESP]
Gadelha Rocha, Marcos Fabio [UNIFESP]
Pereira, Sandro Antonio
Ferreira Gremiao, Isabella Dib
Pacheco Schubach, Tania Maria
de Camargo, Zoilo Pires [UNIFESP]
dc.subject.eng.fl_str_mv Sporothrix brasiliensis
cats
antifungal susceptibility
sporotrichosis
Sporothrix schenckii complex
topic Sporothrix brasiliensis
cats
antifungal susceptibility
sporotrichosis
Sporothrix schenckii complex
description Sporotrichosis is an important subcutaneous mycosis of humans and animals. Classically, the disease is acquired upon traumatic inoculation of Sporothrix propagules from contaminated soil and plant debris. In addition, the direct horizontal transmission of Sporothrix among animals and the resulting zoonotic infection in humans highlight an alternative and efficient rout of transmission through biting and scratching. Sporothrix brasiliensis is themost virulent species of the Sporothrix schenckii complex and is responsible for the long-lasting outbreak of feline sporotrichosis in Brazil. However, antifungal susceptibility data of animal-borne isolates is scarce. Therefore, this study evaluated the in vitro activity of amphotericin B, caspofungin, itraconazole, voriconazole, fluconazole, and ketoconazole against animal-borne isolates of S. brasiliensis. The susceptibility tests were performed through broth microdilution (M38-A2). The results show the relevant activity of itraconazole, amphotericin B, and ketoconazole against S. brasiliensis, with the following MIC ranges: 0.125-2, 0.125-4 and 0.0312-2 mu g/ml, respectively. Caspofungin was moderately effective, displaying higher variation in MIC values (0.25-64 mu g/ml). Voriconazole (2-64 mu g/ml) and fluconazole (62.5-500 mu g/ml) showed low activity against S. brasiliensis strains. This study contributed to the characterization of the in vitro antifungal susceptibility of strains of S. brasiliensis recovered from cats with sporotrichosis, which have recently been considered the main source of human infections.
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2020-08-21T17:00:09Z
dc.date.available.fl_str_mv 2020-08-21T17:00:09Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Medical Mycology. Oxford, v. 54, n. 3, p. 275-279, 2016.
dc.identifier.uri.fl_str_mv https://repositorio.unifesp.br/handle/11600/57889
http://dx.doi.org/10.1093/mmy/myv039
dc.identifier.issn.none.fl_str_mv 1369-3786
dc.identifier.doi.none.fl_str_mv 10.1093/mmy/myv039
dc.identifier.wos.none.fl_str_mv WOS:000372105200007
identifier_str_mv Medical Mycology. Oxford, v. 54, n. 3, p. 275-279, 2016.
1369-3786
10.1093/mmy/myv039
WOS:000372105200007
url https://repositorio.unifesp.br/handle/11600/57889
http://dx.doi.org/10.1093/mmy/myv039
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Medical Mycology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 275-279
dc.coverage.none.fl_str_mv Oxford
dc.publisher.none.fl_str_mv Oxford Univ Press
publisher.none.fl_str_mv Oxford Univ Press
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1783460274104172544